Single Ascending Doses of HER-096 in Healthy Subjects

Clinical trial NCT05915247 · COMPLETED

Trial details

NCT number: NCT05915247
Sponsor: Herantis Pharma Plc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2023-03-29
Primary completion: 2023-09-29
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.